(Q28247457)

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Cardiac cell therapy: where we've been, where we are, and where we should be headed

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Somatic coding mutations in human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Immunogenicity of induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Bone marrow cells regenerate infarcted myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Cell therapy of acute myocardial infarction: open questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Evidence for cardiomyocyte renewal in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Cardiomyogenesis in the adult human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Stem cells in the heart: what's the buzz all about?--Part 1: preclinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Dedifferentiation and proliferation of mammalian cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Transient regenerative potential of the neonatal mouse heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Adult cardiac stem cells are multipotent and support myocardial regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Results of intracoronary stem cell therapy after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Determinants of functional recovery after myocardial infarction of patients treated with bone marrow-derived stem cells after thrombolytic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Promise of blood- and bone marrow-derived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Cell therapy for ischaemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Cell-based cardiac repair: reflections at the 10-year point

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction: first-in-man study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Diagnostic and prognostic value of 3D NOGA mapping in ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Assessment and optimization of cell engraftment after transplantation into the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Paracrine mechanisms in adult stem cell signaling and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Aging and disease as modifiers of efficacy of cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

Induced pluripotent stem cells: developmental biology to regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

7 January 2021

Isolation and expansion of adult cardiac stem cells from human and murine heart

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

7 January 2021

Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Int

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

7 January 2021

Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.175

7 January 2021